SCHEMBL7745318

SCHEMBL7745318

COC(=S)NC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7745326 0.90
SCHEMBL7752559 0.90 SMN1; SMN2 (0.61)
SCHEMBL7745314 0.78
SCHEMBL11562573 0.76 SMN1; SMN2 (0.82)
SCHEMBL1544580 0.72
SCHEMBL863150 0.71
SCHEMBL8551209 0.71 GAA (0.58)
SCHEMBL12217721 0.70 KDM4E (0.40)
SCHEMBL3077689 0.69 ALDH1A1 (0.68)
SCHEMBL7745323 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001040245-A1 N6 HETEROCYCLIC 5' MODIFIED ADENOSINE DERIVATIVES CV THERAPEUTICS, INC. (US) 2001-06-07 WO disclosed
WO-2001040244-A1 N6 HETEROCYCLIC 5' MODIFIED ADENOSINE DERIVATIVES CV THERAPEUTICS, INC. (US) 2001-06-07 WO disclosed